Director/PDMR Shareholding
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, announces that it was notified on 25 September 2023 that on the same day, Chris Meredith, Director, purchased 23,000 ordinary shares of 5p each (“Ordinary Shares”) at a price of 192.37p per Ordinary Share and that Eddie Johnson, Director, purchased 21,174 Ordinary Shares of 5p each at a price of 193.6p per Ordinary Share.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||||||
|
a) |
Name: (i) Chris Meredith (ii) Eddie Johnson |
||||||
|
2. |
Reason for the notification |
||||||
|
a) |
Position/status: (i) Chief Executive Officer (ii) Chief Financial Officer |
||||||
|
b) |
Initial notification/Amendment: Initial Notification |
||||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||
|
a) |
Name: Advanced Medical Solutions Group plc |
||||||
|
b) |
LEI: 213800HJP6OWOSZI1L74 |
||||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||
|
a) |
Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 |
||||||
|
b) |
Nature of the transactions: · Purchase of Ordinary Shares |
||||||
|
c) |
Price(s) and volume(s):
|
||||||
|
d) |
Aggregated information: N/A |
||||||
|
e) |
Date of the transaction: 25/09/2023 |
||||||
|
f) |
Place of the transaction: London Stock Exchange, AIM Market (XLON) |
– End –